FDA Applied Next-Gen Sequencing to Retrospectively Analyze Food-Borne Pathogens | GenomeWeb

By Turna Ray

This article was originally posted on March 10.

Next-generation sequencing techniques helped the US Food and Drug Administration to retrospectively analyze foodborne illnesses caused by a hard-to-locate bacteria strain, the agency announced earlier this month. However, the speed and cost of such technology will have to improve before the FDA uses next-generation sequencing to characterize food-borne illnesses and determine treatment strategies bases on test results in real time.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.